Nanobiomaterials in Cancer Therapy, discusses the most important findings in the field of cancer treatment. Novel therapeutic approaches utilize nanobiomaterials able to significantly enhance drug-loading capacity, formulation stability, and improve the efficiency of the drug. This book highlights the fabrication methods of platforms for multimodal and combinatorial therapeutic options along with simultaneous and real-time cancer imaging and innovative approaches for oncology by passive or active pathways of multifunctional nanocarriers. Engineered nanobiosystems for cancer therapy, prevention, low cancer recurrence, or relapse are also revealed and discussed. Volume VII contains 15 chapters, prepared by outstanding international researchers from the United States of America, Portugal, the United Kingdom, France, Mauritius, Romania, Russia, India, China, and Singapore. In Chapter 4, Advances in Nanobiomaterials for Oncology Nanomedicine, Patrıcia Severino et al. present an up-to-date review regarding nanobiostructures used for the development of innovative approaches for oncology by passive or active pathways.
Advances in nanobiomaterials for oncology nanomedicine / Patrıcia, Severino; Luciana M., De Hollanda; Santini, Antonello; Lucinda V., Reis; Selma B., Souto; Eliana B., Souto; Amelia M., Silva. - 7:(2016), pp. 91-115. [10.1016/B978-0-323-42863-7.00001-3]
Advances in nanobiomaterials for oncology nanomedicine.
SANTINI, ANTONELLO;
2016
Abstract
Nanobiomaterials in Cancer Therapy, discusses the most important findings in the field of cancer treatment. Novel therapeutic approaches utilize nanobiomaterials able to significantly enhance drug-loading capacity, formulation stability, and improve the efficiency of the drug. This book highlights the fabrication methods of platforms for multimodal and combinatorial therapeutic options along with simultaneous and real-time cancer imaging and innovative approaches for oncology by passive or active pathways of multifunctional nanocarriers. Engineered nanobiosystems for cancer therapy, prevention, low cancer recurrence, or relapse are also revealed and discussed. Volume VII contains 15 chapters, prepared by outstanding international researchers from the United States of America, Portugal, the United Kingdom, France, Mauritius, Romania, Russia, India, China, and Singapore. In Chapter 4, Advances in Nanobiomaterials for Oncology Nanomedicine, Patrıcia Severino et al. present an up-to-date review regarding nanobiostructures used for the development of innovative approaches for oncology by passive or active pathways.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
